hsa-miR-3666 |
A-549 |
|
SIRT7 |
Apoptosis pathway |
MicroRNA-3666 down-regulates the expression of SIRT7 and suppresses non-small cell lung cancer cell growth by inducing the Apoptosis pathway. |
Shi et al., 2016 |
hsa-miR-146a |
Lung |
Down |
MIF |
NF-Kappa B signaling pathway |
Overexpression of miR-146a suppresses the expression of MIF and promotes the apoptosis of cancer cells via NF-Kappa B signaling pathway. |
Wang et al., 2016 |
hsa-miR-107 |
Lung |
Down |
BDNF |
PI3K-Akt signaling pathway |
MicroRNA-107 inhibits non-small cell lung cancer metastasis by down-regulating brain-derived neurotrophic factor and indirectly regulating PI3K-Akt signaling pathway. |
Xia et al., 2016 |
hsa-miR-509 |
A-549 |
|
PLK1 |
DNA damage response pathway |
MicroRNA-509-3 functions as a suppressor for cancer by down-regulating PLK1. |
Wang et al., 2016 |
hsa-miR-200c |
A-549 |
Down |
|
Cadherin signaling pathway |
Upregulation of miR-200c suppresses cell migration and invasion with reducing the expression of EZH2 and enhancing the expression of E-cad. |
Shan et al., 2016 |
hsa-miR-106a |
Lung |
Up |
ULK1 |
Autophagy pathway |
MicroRNA-106a inhibits autophagy and increases sensitivity of lung cancer cells to Src inhibitors through miR-106a-ULK1 signaling pathway. |
Rothschild et al., 2016 |
hsa-miR-126 |
A-549 |
Down |
PIK3R2 |
PI3K-Akt signaling pathway |
Over-expression of miR-126 decreases the expression of the target gene PIK3R2 and regulates the PI3K-Akt signaling pathway, inhibiting the proliferation, migration, and invasion of non-small-cell lung cancer. |
Song et al., 2016 |
hsa-miR-128 |
A-549, SPC-A1, NCI-H460, NCI-H1299 |
|
PFKL |
PI3K-Akt signaling pathway |
Upregulation of miR-128 down-regulates phosphofructokinase liver type (PFKL) through a feedback loop that involves suppression of the AKT signaling pathway. |
Yang et al., 2016 |
hsa-miR-223 |
PC-9 |
|
IGF 1R |
IGF signaling pathway |
MicroRNA-223 increases the acquired resistance of non-small cell lung cancer cells to erlotinib through inhibition of the IGF-1R/Akt/S6 signaling pathway. |
Zhao et al., 2016 |
hsa-miR-376c |
Lung |
|
LRH 1 |
Wnt signaling pathway |
MicroRNA-376c suppresses non-small cell lung cancer cell growth and invasion by inhibiting the expression of LRH-1. |
Jiang et al., 2016 |
hsa-miR-194 |
Lung |
Down |
HNUDC |
ERK pathway |
Over-expression of miR-194 suppresses the expression of Mpl/ERK pathway proteins, and inhibits the mitosis and proliferation of non-small cell lung cancer cells. |
Zhou et al., 2016 |
hsa-miR-206 |
A-549 |
Down |
MET |
PI3K-Akt signaling pathway |
Upregulation of miR-206 decreases cisplatin resistance and epithelial-mesenchymal transition through inactivation of MET/PI3K-Akt signaling pathway. |
Chen et al., 2016 |
hsa-miR-223 |
HCC827 |
Up |
|
PI3K-Akt signaling pathway |
Decreased expression of miR-223 is associated with resistance of non-small cell lung cancer cells to erlotinib through the activation of the IGF1R/phosphatidylinositol 3-kinase (PI3K)/PI3K-Akt signaling pathway. |
Han et al., 2016 |
hsa-miR-410 |
Lung |
|
SLC34A2 |
Wnt signaling pathway |
MicroRNA-410 functions as oncogene through inhibiting the expression of SLC34A2 via activating Wnt signaling pathway in non-small cell lung cancer. |
Zhang et al., 2016 |
hsa-miR-26b |
Lung |
Down |
MIEN1 |
NF-Kappa B signaling pathway |
MicroRNA-26b inhibits non-small cell lung cancer metastasis by suppressing MIEN1 through NF-Kappa B signaling pathways. |
Li et al., 2016 |
hsa-miR-124 |
Lung |
Down |
SMAD4 |
TGF-beta signaling pathway |
The feedback loop between miR-124 and TGF-beta signaling pathway play an important role in non-small cell lung cancer metastasis. |
Zu et al., 2016 |
hsa-miR-208a |
Lung |
Up |
P21 |
mTOR pathway |
MicroRNA-208a regulates the proliferation and radiosensitivity of human lung cancer cells by direct inhibition of p21. |
Tang et al., 2016 |
hsa-miR-452 |
Lung |
Down |
BMI 1 |
PI3K-Akt signaling pathway |
MicroRNA-452 inhibits non-small cell lung cancer cell epithelial-mesenchymal transition (EMT) through inactivating PI3K-Akt signaling pathway. |
Zhang et al., 2016 |
hsa-miR-708 |
Lung |
Down |
P21 |
PI3K-Akt signaling pathway |
Upregulation of the miRNA-708 inhibits cell survival and metastasis through its direct target p21, and suppresses the PI3K-Akt signaling pathway and stem cell-like characteristics of lung cancer cells. |
Wu et al., 2016 |
hsa-miR-34a |
|
|
AXL |
JNK signaling pathway |
AXL is autoregulated by miR-34a in a feedback loop and promotes apoptosis in lung cancer cells. |
Cho et al., 2016 |
hsa-miR-122 |
Lung |
Down |
|
PI3K-Akt signaling pathway |
MicroRNA-122 inhibits the epithelial-mesenchymal transition process by suppressing PI3K/AKT activation through decreasing endogenous expression of insulin-like growth factor 1 receptor. |
Qin et al., 2015 |
hsa-miR-7 |
Lung |
|
SMARCD1 |
Apoptosis pathway |
MicroRNA-7 suppresses p53-dependent apoptosis-related gene BAX (BCL2-associated X protein) and expression of p21 by interfering with the interaction between SMARCD1 and p53, thereby decreasing caspase3 cleavage and the downstream apoptosis cascades. |
Hong et al., 2016 |
hsa-miR-26a |
Lung |
|
HMGA2 |
PI3K-Akt signaling pathway |
Down-regulation of miR-26a plays an important role in the mechanism of cisplatin resistance in human non-small cell lung cancer via HMGA2-mediated E2F1-PI3K-Akt signaling pathway. |
Yang et al., 2016 |
hsa-miR-582 |
Lung |
Up |
AXIN2 |
Wnt signaling pathway |
Upregulation of miR-582 down-regulates the expression of AXIN2, the negative regulators of the Wnt signaling pathway. |
Fang et al., 2015 |
hsa-miR-582 |
Lung |
Up |
DKK3 |
Wnt signaling pathway |
Overexpressed miR-582 regulates lung cancer stem cell-like traits by activating Wnt-beta-catenin signaling through targeting DKK3. |
Fang et al., 2015 |
hsa-miR-582 |
Lung |
Up |
SFRP1 |
Wnt signaling pathway |
Increased expression of miR-582 inhibits the expression of SFRP1, the negative regulators of the Wnt signaling pathway. |
Fang et al., 2015 |
hsa-miR-33b |
Lung |
Down |
ZEB1 |
Wnt signaling pathway |
MicroRNA-33b suppresses cell growth, invasion, and epithelial-mesenchymal transition in lung adenocarcinoma by targeting Wnt signaling pathway. |
Qu et al., 2015 |
hsa-miR-93 |
A-549, MRC-5 |
|
ZNRF3 |
Wnt signaling pathway |
MicroRNA-93 functions as an oncogenic microRNA for lung cancer progression through inhibiting Wnt signaling pathway. |
Shi et al., 2016 |
hsa-miR-144 |
Lung |
Down |
ZEB1 |
Zeb1 signaling pathway |
Overexpression of miR-144 inhibits non-small cell lung cancers through down-regulating Zeb1. |
Pan et al., 2015 |
hsa-miR-10a |
Lung |
Up |
PTEN |
PI3K-Akt signaling pathway |
Upregulation of miR-10a enhances non-small cell lung cancer cell proliferation, migration and invasion through targeting PTEN. |
Yu et al., 2015 |
hsa-miR-452 |
Lung |
Down |
BMI 1 |
BMI1 pathway |
Overexpression of MiR-452 suppresses metastasis through targeting BMI1 in non-small cell lung cancer. |
He et al., 2015 |
hsa-miR-224 |
Lung |
Up |
CASPASE 3 |
NF-Kappa B signaling pathway |
MicroRNA-224 plays an important role in the lung cancer pathogenesis through down-regulating the expression of CASP3. |
Cui et al., 2015 |
hsa-miR-224 |
Lung |
Up |
CASPASE 7 |
NF-Kappa B signaling pathway |
MicroRNA-224 plays an important role in the lung cancer pathogenesis through down-regulating the expression of CASP7. |
Cui et al., 2015 |
hsa-miR-31 |
A-549 |
Up |
MET |
PI3K-Akt signaling pathway |
MicroRNA-31 suppresses the growth of lung adenocarcinoma cancer stem-like cells through inhibition of the MET-PI3K-Akt signaling pathway. |
Hou et al., 2016 |
hsa-miR-214 |
A-549,NCI-H1650 |
Up |
CTNNBIP1 |
Wnt signaling pathway |
MicroRNA-214 plays an important role in cancer stem-like cells self-renewal and stemness by down-regulating the expression of CTNNBIP1 in lung adenocarcinoma. |
Qi et al., 2015 |
hsa-miR-34c |
Lung |
Down |
PAC1 |
MAPK signaling pathway |
Upregulation of miR-34c inhibits cell proliferation, colony formation, migration and invasion by suppressing PAC1/MAPK signaling pathway. |
Zhou et al., 2015 |
hsa-miR-134 |
H69 |
Up |
WWOX |
ERK pathway |
MicroRNA-134 regulates cell proliferation and inhibits apoptosis through the activation of ERK1/2 pathway. |
Chen et al., 2015 |
hsa-miR-203 |
Lung |
Up |
FZD2 |
Wnt signaling pathway |
MicroRNA-203 directly inhibits cancer metastasis through Wnt signaling pathway by targeting FZD2. |
Mine et al., 2015 |
hsa-miR-494 |
HUVEC |
|
PTEN |
PI3K-Akt signaling pathway |
MicroRNA-494 regulates angiogenesis by down-regulating PTEN and activates PI3K-Akt signaling pathway. |
Mao et al., 2015 |
hsa-miR-30a |
Lung |
Down |
IGF1R |
PI3K-Akt signaling pathway |
MicroRNA-30a inhibits non-small cell lung cancer cells progression via PI3K-Akt signaling pathway by down-regulating the expression of IGF1R. |
Wen et al., 2015 |
hsa-miR-675 |
Lung |
Down |
GPR55 |
GPR55 signaling pathway |
MicroRNA-675 acts as a tumor suppressor through the inhibition of GPR55 in non-small cell lung cancer. |
He et al., 2015 |
hsa-miR-21 |
Lung |
Up |
PTEN |
NF-Kappa B signaling pathway |
Suppression of NF-Kappa B signaling pathway enhances cisplatin sensitivity in non-small cell lung cancer. |
Yang et al., 2015 |
hsa-miR-99a |
Lung |
Down |
IGF 1R |
IGF signaling pathway |
MicroRNA-99a promotes proliferation, colony formation and migration through the IGF-1R pathway in non-small cell lung cancer. |
Chen et al., 2015 |
hsa-miR-10a |
A-549 |
Up |
|
TGF-beta signaling pathway |
MicroRNA-10a is the potential target for improving the effectiveness of lung cancer chemotherapy through the regulation of the TGF-beta/Smad2/STAT3/STAT5 pathway. |
Sun et al., 2015 |
hsa-miR-145 |
A-549 |
Down |
|
Wnt signaling pathway |
hsa-miR-145 suppresses lung cancer cell metastasis and epithelial mesenchymal transition through inhibiting the Oct4 mediated Wnt signaling pathway. |
Ling et al., 2015 |
hsa-miR-15a |
A-549 |
|
TLR1 |
NF-Kappa B signaling pathway |
MicroRNA-15a increases radiation sensitivity through NF-Kappa B signaling pathway by targeting TLR1. |
Lan et al., 2015 |
hsa-miR-16 |
A-549 |
|
TLR1 |
NF-Kappa B signaling pathway |
MicroRNA-16 increases radiation sensitivity through NF-Kappa B signaling pathway by targeting TLR1. |
Lan et al., 2015 |
hsa-miR-16 |
Lung |
Down |
BCL 2 |
Caspase 3 pathway |
Overexpression of miR-16 enhances paclitaxel induced apoptotic cell death by inhibiting anti-apoptotic protein Bcl-2. |
Chatterjee et al., 2015 |
hsa-miR-17 |
Lung |
Down |
BECLIN 1 |
Caspase 3 pathway |
Upregulation of miR-17 decreases cytoprotective autophagy by down-regulating the expression of Beclin-1. |
Chatterjee et al., 2015 |
hsa-miR-141 |
Lung |
Down |
CXCL1 |
CXCL1-CXCR2 pathway |
MicroRNA-141 significantly suppresses tumor growth and metastasis by targeting CXCL1 in non-small cell lung cancer. |
Lv et al., 2015 |
hsa-miR-21 |
A-549 |
Up |
|
PI3K-Akt signaling pathway |
Inhibition of miR-21 reverses lung cancer cell multi drug resistance through inhibition of the Akt signaling pathway. |
Dong et al., 2015 |
hsa-miR-3127 |
Lung |
Down |
ABL1 |
ERK pathway |
MicroRNA-3127 expression levels are associated with dasatinib sensitivity in non-small cell lung cancer through the c-Abl/Ras/ERK pathway. |
Sun et al., 2014 |
hsa-miR-191 |
HBE |
Up |
BASP1 |
Wnt signaling pathway |
MicroRNA-191 regulates the epithelial-mesenchymal transition and the cancer stem cell-like properties of transformed cells. |
Xu et al., 2015 |
hsa-miR-548l |
Lung |
Down |
AKT |
AKT1 signaling pathway |
miR-548l plays an important role in non-small cell lung cancer invasion and metastasis through AKT1. |
Liu et al., 2015 |
hsa-miR-99a |
Lung |
Down |
AKT |
AKT1 signaling pathway |
MicroRNA-99a plays an important role in the tumorigenesis and metastasis of non-small cell lung cancer by inhibiting AKT1 signaling pathway. |
Yu et al., 2015 |
hsa-miR-203 |
A-549, H1975, HCC827 |
|
SRC |
ERK pathway |
MicroRNA-203 inhibits the proliferation and migration and enhances the apoptosis of lung cancer cells by down-regulating the expression of SRC. |
Wang et al., 2014 |